Matako, Y.; Suttisingtong, K.; Boonsombat, J.; Sirirak, J.; Limpachayaporn, P. The Synthetic Pathways of a New 1,2,3-Triazole-Containing Sorafenib Analogue and Its Cytotoxicity towards Cancer Cell Lines. rmutsvrj 2021, 13, 244–258.

01 May 2021
0

Matako, Y.; Suttisingtong, K.; Boonsombat, J.; Sirirak, J.; Limpachayaporn, P. The Synthetic Pathways of a New 1,2,3-Triazole-Containing Sorafenib Analogue and Its Cytotoxicity towards Cancer Cell Lines. rmutsvrj 202113, 244–258.

Tags

Share this

Related Posts

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)